Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
524
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
29 Oct 2025 19:45
•
Broker
Mirae Asset Minutes [2025: Volume 20] Biweekly Strategy Meeting Recap
Global equities are likely to remain on an upward trend, supported by favorable liquidity conditions and optimism surrounding AI ecosystem growth
Mirae Asset Securities
Follow
514 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Oct 2025 08:30
APAC Healthcare Weekly (October 26) – Innovent, Akeso, Celltrion, Classys, Daiichi, Syngene, Cipla
Innovent Biologics announced collaboration with Takeda. FDA approves two additional indications for Celltrion's Humira biosimilar. Syngene is...
Tina Banerjee
Follow
896 Views
Share
bullish
•
Quantitative Analysis
•
27 Sep 2026 10:20
KRX Foreign Holding Weekly (Sep 25th): Samsung Electronics, SK Hynix, SamsungElecMech, SKSQUARE
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, SamsungElecMech,...
Ke Yan, CFA, FRM
Follow
106 Views
Share
bullish
•
Thematic (Sector/Industry)
•
19 Oct 2025 08:30
APAC Healthcare Weekly (October 19) – Hansoh, Leads Biolabs, Chugai, SanBio, Celltrion, Samsung Bio
Hansoh and Leads Biolabs bag global outlicensing deals. Chugai’s partner Lilly announced positive P3 result for orforglipron. Celltrion launched...
Tina Banerjee
Follow
1k Views
Share
bullish
•
Thematic (Sector/Industry)
•
15 Oct 2025 19:52
•
Broker
Mirae Asset Minutes [2025: Volume 19]Biweekly strategy meeting recap
While AI-related demand from hyperscalers and governments is surging, demand for commodity memory remains uncertain, leading to limited capacity...
Mirae Asset Securities
Follow
476 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x